The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide Is BPC 157 Banned? Oral vs. Injectable Forms Explained How different peptide therapies may affect your body Prenuvo blog New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,